Moreover, in tumor-infiltrating regulatory T cells (Tregs), USP39 has been identified to increase RNA splicing-mediated CTLA-4 expression, which in turn enhances the immunosuppressive function of Tregs, thereby suppressing anti-tumor immunity. The gene discussed is USP39; the disease is neoplasm.